# Nordic Science Investments

Nordic Science Investments is a Private Equity based in Helsinki, Finland.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Helsinki, Finland
- **Region:** Europe
- **Address:** Helsinki, Finland
- **Assets under management:** Undisclosed
- **Website:** nordscience.fi
- **LinkedIn:** https://www.linkedin.com/company/nordic-science-investments-oy

## Regulatory record

- **Reports private funds:** No

## About

Nordic Science is a Helsinki-based venture capital firm. It partners with university research teams to commercialize scientific discoveries, providing financial capital and resources. The firm has made 24 investments, including a Seed VC investment in CubaseBio on February 17, 2026.

## Sectors

- Deep Tech
- Health Tech
- Life Sciences

## People

- Alexandra Gylfe — Founding Partner
- Jari Strandman — Founding Partner
- Gerard de Bourbon — Partner
- Mart Maasik — Partner

## Questions

### How does Nordic Science Investments source its startup pipeline?

NSI partners directly with university innovation offices and tech-transfer teams across the New Nordics, evaluating IP before formal spinout. This integration with academic screening processes gives the firm early visibility on commercialization-ready research, rather than relying solely on inbound founder pitches.

### What is the relationship between Nordic Science Investments and SmartCap?

In December 2025, SmartCap Venture Capital Fund — a state-backed Estonian fund-of-funds — invested €3 million into NSI (per firm website, December 2025). The commitment is designed to strengthen early-stage deep-tech investment across Estonia and the wider Baltic-Nordic corridor.

### What investment stages does NSI typically target?

NSI’s sweet spot is pre-seed, where it anchors university spinouts with €50–100k tickets. The firm provides full follow-on capacity through Series B, scaling its checks to €400–600k at seed, €1–1.5M at Series A, and up to €3.5M for later rounds (per firm website).

### Which sectors does Nordic Science Investments explicitly avoid?

The firm concentrates exclusively on deeptech, healthtech, and life sciences. Consumer internet, enterprise SaaS without hard-science moats, and capital-light service businesses are not part of the mandate.

### Does NWI operate solely in Finland, or does it have a broader geographic footprint?

While headquartered in Helsinki, NSI’s investment scope covers what it calls the 'New Nordics,' with active portfolio companies in Estonia and Finland. The addition of Estonian-based Partner Mart Maasik and the SmartCap relationship reinforce the multi-country strategy.

### What is the firm's known posture on co-investments alongside external VCs?

NSI actively co-invests, positioning itself as a deal anchor for other funds. It has publicly referenced a partnership with Taaleri and notes that co-investors are welcome at the seed round, with the aim of de-risking startups for follow-on institutional capital.

### Who makes the final investment decisions at Nordic Science Investments?

The firm does not publicly disclose its investment committee structure, but the four named partners — Alexandra Gylfe, Jari Strandman, Gerard de Bourbon, and Mart Maasik — collectively represent the senior deal-making layer as listed on the firm's contact page.

## Related profiles

- [Nordic Option](https://altss.com/profile/nordic-option)
- [Nordic Secondary Fund](https://altss.com/profile/nordic-secondary-fund)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/nordic-science-investments

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology